In the original published version of this article, Amanda Orzechowski was incorrectly listed as an author. This person has requested that they be removed as an author. Both the HTML and PDF versions of the article have been updated to correct the error.
. 2019 Mar 18;5(3):e01309. doi: 10.1016/j.heliyon.2019.e01309
Corrigendum to “Targeting B7-H1 (PD-L1) sensitizes cancer cells to chemotherapy” [Heliyon 4 (12) (December 2018) e01039]
Xiaosheng Wu
a, Yanli Li
b,1, Xin Liu
b, Chunhua Chen
c, Susan M Harrington
b, Siyu Cao
b, Tiancheng Xie
b, Tu Pham
d, Aaron S Mansfield
e, Yiyi Yan
e, Eugene D Kwon
b,d, Liewei Wang
f, Kun Ling
c, Haidong Dong
b,d,∗
Xiaosheng Wu
aDepartment of Medicine Division of Hematology, Mayo Clinic College of Medicine, Rochester, MN, USA
Find articles by Xiaosheng Wu
Yanli Li
bDepartment of Urology, Mayo Clinic College of Medicine, Rochester, MN, USA
Find articles by Yanli Li
Xin Liu
bDepartment of Urology, Mayo Clinic College of Medicine, Rochester, MN, USA
Find articles by Xin Liu
Chunhua Chen
cDepartment of Biochemistry and Molecular Biology, Mayo Clinic College of Medicine, Rochester, MN, USA
Find articles by Chunhua Chen
Susan M Harrington
bDepartment of Urology, Mayo Clinic College of Medicine, Rochester, MN, USA
Find articles by Susan M Harrington
Siyu Cao
bDepartment of Urology, Mayo Clinic College of Medicine, Rochester, MN, USA
Find articles by Siyu Cao
Tiancheng Xie
bDepartment of Urology, Mayo Clinic College of Medicine, Rochester, MN, USA
Find articles by Tiancheng Xie
Tu Pham
dDepartment of Immunology, Mayo Clinic College of Medicine, Rochester, MN, USA
Find articles by Tu Pham
Aaron S Mansfield
eDivision of Medical Oncology, Mayo Clinic College of Medicine, Rochester, MN, USA
Find articles by Aaron S Mansfield
Yiyi Yan
eDivision of Medical Oncology, Mayo Clinic College of Medicine, Rochester, MN, USA
Find articles by Yiyi Yan
Eugene D Kwon
bDepartment of Urology, Mayo Clinic College of Medicine, Rochester, MN, USA
dDepartment of Immunology, Mayo Clinic College of Medicine, Rochester, MN, USA
Find articles by Eugene D Kwon
Liewei Wang
fDepartment of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic College of Medicine, Rochester, MN, USA
Find articles by Liewei Wang
Kun Ling
cDepartment of Biochemistry and Molecular Biology, Mayo Clinic College of Medicine, Rochester, MN, USA
Find articles by Kun Ling
Haidong Dong
bDepartment of Urology, Mayo Clinic College of Medicine, Rochester, MN, USA
dDepartment of Immunology, Mayo Clinic College of Medicine, Rochester, MN, USA
Find articles by Haidong Dong
aDepartment of Medicine Division of Hematology, Mayo Clinic College of Medicine, Rochester, MN, USA
bDepartment of Urology, Mayo Clinic College of Medicine, Rochester, MN, USA
cDepartment of Biochemistry and Molecular Biology, Mayo Clinic College of Medicine, Rochester, MN, USA
dDepartment of Immunology, Mayo Clinic College of Medicine, Rochester, MN, USA
eDivision of Medical Oncology, Mayo Clinic College of Medicine, Rochester, MN, USA
fDepartment of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic College of Medicine, Rochester, MN, USA
∗
Corresponding author. Dong.Haidong@mayo.edu
1
Current address: Life science institution, Shanghai University, Shanghai, China.
Received 2019 Feb 27; Accepted 2019 Feb 28; Collection date 2019 Mar.
© 2018 The Author
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
PMCID: PMC6426698 PMID: 30937406
This corrects the article "Targeting B7-H1 (PD-L1) sensitizes cancer cells to chemotherapy" in volume 4, e01039.